SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-048380
Filing Date
2024-04-25
Accepted
2024-04-25 16:30:26
Documents
16
Period of Report
2024-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A rvmd-20240425.htm   iXBRL DEF 14A 1592265
2 GRAPHIC img29261561_0.jpg GRAPHIC 743546
3 GRAPHIC img29261561_1.jpg GRAPHIC 199772
4 GRAPHIC img29261561_2.jpg GRAPHIC 155656
5 GRAPHIC img29261561_3.jpg GRAPHIC 528943
6 GRAPHIC img29261561_4.jpg GRAPHIC 183078
  Complete submission text file 0000950170-24-048380.txt   6283712

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rvmd-20240425.xsd EX-101.SCH 23988
19 EXTRACTED XBRL INSTANCE DOCUMENT rvmd-20240425_htm.xml XML 166580
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39219 | Film No.: 24876855
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)